Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
Johnson and Johnson

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 3,950,405

« Back to Dashboard

Summary for Patent: 3,950,405

Title: Trans-4-aminomethylcyclohexane-1-carboxylic acid
Abstract:A trans isomer of 4-cyanoncyclohexane-1-carboxylic acid or its lower alkyl ester is reduced in a solvent in the presence of a hydrogenating catalyst, and hydrolyzing the produced ester in case the starting trans-isomer is a lower alkyl ester, then the trans-4-aminomethyl-cyclohexane-1-carboxylic acid is recovered from the reaction mixture.
Inventor(s): Okano; Atsuji (Otsuka, JA), Kadoya; Shizuo (Yokohama, JA), Naito; Takeo (Ichikawa, JA), Aoyagi; Takaaki (Fujisawa, JA), Shimizu; Masao (Otsukanaka, JA)
Assignee: Mitsubishi Chemical Industries Ltd. (Tokyo, JA)
Application Number:04/836,196
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 3,950,405

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
46-69632Dec 24, 1971

International Patent Family for Patent: 3,950,405

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Belgium657492► Subscribe
Brazil6465652► Subscribe
Switzerland444146► Subscribe
Germany1443755► Subscribe
Germany1793841► Subscribe
France1455813► Subscribe
United Kingdom1094876► Subscribe
JapanS4822692► Subscribe
Netherlands149784► Subscribe
Netherlands6414942► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: